Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 USD | +1.11% | +46.10% | +25.52% |
Apr. 23 | VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech | CI |
Mar. 26 | Transcript : VolitionRx Limited, Q4 2023 Earnings Call, Mar 26, 2024 |
Business Summary
Number of employees: 110
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Blood Tests
77.2
%
| 0 | 68.9 % | 1 | 77.2 % | +183.64% |
Service
22.6
%
| 0 | 30.2 % | 0 | 22.6 % | +89.73% |
Royalty
0.2
%
| 0 | 1.0 % | 0 | 0.2 % | -52.97% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +153.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 11-10-05 |
Terig Hughes
DFI | Director of Finance/CFO | 54 | 21-01-31 |
Gaetan Michel
COO | Chief Operating Officer | 51 | 21-01-31 |
Mark Eccleston
CTO | Chief Tech/Sci/R&D Officer | 42 | - |
Jacob Micallef
CTO | Chief Tech/Sci/R&D Officer | 67 | 14-12-31 |
Scott Powell
IRC | Investor Relations Contact | 51 | 14-04-30 |
Louise Batchelor
IRO | Public Communications Contact | - | 16-04-13 |
Terry Kelly
PRN | Corporate Officer/Principal | - | 20-02-29 |
Gael Forterre
PRN | Corporate Officer/Principal | 43 | 21-01-31 |
Rodney Rootsaert
SEC | Corporate Secretary | 52 | 11-10-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 11-10-05 |
Martin Faulkes
CHM | Chairman | 80 | 11-10-05 |
Guy Innes
BRD | Director/Board Member | 67 | 11-10-05 |
Alan Colman
BRD | Director/Board Member | 75 | 11-10-05 |
Edward Futcher
BRD | Director/Board Member | 69 | 16-06-22 |
Phillip Barnes
BRD | Director/Board Member | 62 | 19-10-08 |
Kim Nguyen
BRD | Director/Board Member | 47 | 21-03-24 |
Mickie Henshall
BRD | Director/Board Member | 52 | 22-08-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 82,068,442 | 62,437,547 ( 76.08 %) | 0 | 76.08 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.15% | 73.05M | |
-19.56% | 10.67B | |
+41.64% | 3.22B | |
-35.30% | 2.09B | |
-18.92% | 2.04B | |
-28.86% | 1.46B | |
+19.01% | 1B | |
-4.37% | 734M | |
-35.66% | 391M | |
-45.82% | 379M |
- Stock Market
- Equities
- VNRX Stock
- Company VolitionRx Limited